Pilot Text Message for Influenza Vaccination
This study is not yet open for participant recruitment.
Verified January 2013 by Columbia University
Sponsor:
Columbia University
Information provided by (Responsible Party):
Melissa Stockwell, MD, MPH, Columbia University
ClinicalTrials.gov Identifier:
NCT01761734
First received: December 30, 2012
Last updated: January 4, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in racial/ethnic minority groups. In order to address the problem of low influenza vaccination rates in minority adults, we plan to build on the well-accepted practice of immunization recall-reminders and the emerging practice of using text message to pilot the feasibility of using text messaging to improve influenza vaccination coverage rates in a low health literacy, largely minority, publicly insured adult population.
| Condition | Intervention |
|---|---|
|
Influenza |
Behavioral: text message |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Health Services Research |
| Official Title: | Pilot Study of Text Message Reminders for Flu Vaccine For Adults |
Resource links provided by NLM:
MedlinePlus related topics:
Flu
Drug Information available for:
Influenza Vaccines
U.S. FDA Resources
Further study details as provided by Columbia University:
Primary Outcome Measures:
- Receipt of an influenza vaccine dose [ Time Frame: March 31, 2013 ] [ Designated as safety issue: No ]Proportion of individuals in each group receiving an influenza dose by the end of the influenza season
| Estimated Enrollment: | 1000 |
| Study Start Date: | January 2013 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: text message
receipt of text message
|
Behavioral: text message |
|
No Intervention: usual care
usual care
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- > or = 18 years of age,
- at least one visit to the AIM clinic during the previous year
- a cell phone number in the registration system
- fluent in English or Spanish. Exclusion criteria
Exclusion Criteria:
- Receipt of influenza vaccination during the 2012-2013 influenza season prior to randomization.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01761734
Contacts
| Contact: Melissa Stockwell, MD MPH | 212-342-5732 | mss2112@columbia.edu |
Locations
| United States, New York | |
| Columbia University | Not yet recruiting |
| New York, New York, United States, 10032 | |
| Contact: Melissa Stockwell, MD MPH 212-342-5732 mss2112@columbia.edu | |
| Principal Investigator: Melissa Stockwell, MD MPH | |
| Principal Investigator: Steven Shea, MD MS | |
| Principal Investigator: Jessica Singer, MD MPH | |
| Sub-Investigator: Marina Catallozzi, MD MSCE | |
Sponsors and Collaborators
Columbia University
Investigators
| Principal Investigator: | Melissa Stockwell, MD MPH | Columbia University |
| Principal Investigator: | Steven Shea, MD MS | Columbia University |
| Principal Investigator: | Jessica Singer, MD MPH | Columbia University |
More Information
No publications provided
| Responsible Party: | Melissa Stockwell, MD, MPH, Assistant Professor of Pediatrics and Population and Family Health, Columbia University |
| ClinicalTrials.gov Identifier: | NCT01761734 History of Changes |
| Other Study ID Numbers: | AAAK5058 |
| Study First Received: | December 30, 2012 |
| Last Updated: | January 4, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Columbia University:
|
Influenza vaccination |
Additional relevant MeSH terms:
|
Influenza, Human Orthomyxoviridae Infections RNA Virus Infections |
Virus Diseases Respiratory Tract Infections Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on June 18, 2013